References
- Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol. 2009;51:580-592. https://doi.org/10.1111/j.1469-8749.2009.03351.x
- Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2014;34:496-505. https://doi.org/10.1016/j.cpr.2014.05.005
- Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and developmen. Am J Clin Nutr. 1991;54:438-463. https://doi.org/10.1093/ajcn/54.3.438
- Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505. https://doi.org/10.1080/07315724.2002.10719248
- Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol. 2006;98:27-33.
- De CR. n-3 fatty acids in cardiovascular disease, N Engl J Med. 2011;364:2439-2450. https://doi.org/10.1056/NEJMra1008153
- Gotto A, Pownall H. Manual of lipid disorders. 3rd ed. London: Lippincot and Williams; 2002.
- Han KH. Omega-3-fatty acid and triglyceride. Korean J Med. 2012;83:724-727. https://doi.org/10.3904/kjm.2012.83.6.724
- Hardman WE. (n-3) Fatty acids and cancer therapy. J Nutr. 2004;134:3427-3430. https://doi.org/10.1093/jn/134.12.3427S
- Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology. 2001;58:283-288. https://doi.org/10.1016/S0090-4295(01)01116-5
- Rose DP, Connoly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217-244. https://doi.org/10.1016/S0163-7258(99)00026-1
- Atakisi O, Atakisi E, Ozcan A, Karapehlivan M, Kart A. European Review for Medical and Pharmacological Sciences Protective effect of omega-3 fatty acids on diethylnitrosamine toxicity in rats. European Review for Medical and Pharmacological Sciences. 2013;17:467-471.
- Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol. 2008;14:6395-6400. https://doi.org/10.3748/wjg.14.6395
- Hassan KS, Hassan SK, Hijazi EG, Khazim KO. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Ren Fail. 2010;32:1031-1035. https://doi.org/10.3109/0886022X.2010.510231
- Soden JS, Lovell MA, Brown K, Partrick DA, Sokol RJ. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr. 2010;156:327-331. https://doi.org/10.1016/j.jpeds.2009.08.033
- Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Am Heart Assoc. 2002;106:2747-2757.
- Kim JY, Kim DB, Lee HJ. Regulation on health/ functional foods in Korea. Toxicology. 2006;221:112-118. https://doi.org/10.1016/j.tox.2006.01.016
- Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Am Heart Assoc. 2002;106:2747-2757.
- Cho KH, Park YM. Cardiovascular disease and health functional foods. Korean J Fam Med. 2010;31:587-594. https://doi.org/10.4082/kjfm.2010.31.8.587
- Ministry of Health and Welfare, Korea Health Industry Development Institute. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. The 3rd Korea National Health and Nutrition Examination Survey (KNHANES III) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2018 [cited 2018 Mar 07]. Available from: https://knhanes.cdc.go.kr/knhanes/index.do.
- Korean Nutrition Society. 2010 dietary reference intakes for Koreans [Internet]. Seoul: Korean Nutrition Society; 2018 [cited 2018 Mar 07]. Available from: http://www.kns.or.kr/Download/2010KDRIs_open_final.pdf.
- Stroes E, Bruin TD, Davidson M, Yang H, Kvarnstrom M, Lundstrom T. Omega-3 carboxylic acids in severe hypertriglyceridemia: EVOLVE II study results. Atherosclerosis. 2016;252:E232.